In this article from CBC News, they explain how proposed U.S. tariffs on Canadian-made medicines could disrupt cross-border supply chains, increase costs, and risk shortages of essential drugs. Experts warn that many critical medicines, including antibiotics and antidepressants, are manufactured in Canada and exported to the U.S., meaning tariffs could impact both American and Canadian patients. Trade experts caution that escalating economic tension could worsen shortages, drive up prescription costs, and strain health systems already under pressure. The article underscores the urgent need for policies that protect the flow of life-saving medicines and keep public health secure.